Authors: FISHMAN DA VISCARELLO RR CASS I SCHWARTZ PE

Citation: Da. Fishman et al., EFFECT OF COMBINATION CHEMOTHERAPY WITH CISPLATIN AND CYCLOPHOSPHAMIDE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SURROGATE MARKERS IN A PATIENT WITH ADVANCED EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 57(1), 1995, pp. 105-108

Authors: VISCARELLO RR COPPERMAN AB DEGENNARO NJ

Citation: Rr. Viscarello et al., INVASIVE FETAL MONITORING AND HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION - REPLY, American journal of obstetrics and gynecology, 172(1), 1995, pp. 244-244

Authors: JENKINS M LANDERS D WILLIAMSHERMAN D WARA D VISCARELLO RR HAMMILL HA KLINE MW SHEARER WT CHARLEBOIS ED KOHL S

Citation: M. Jenkins et al., ASSOCIATION BETWEEN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ANTIBODY-TITERS AT BIRTH AND VERTICAL TRANSMISSION OF HIV-1, The Journal of infectious diseases, 170(2), 1994, pp. 308-312

Authors: VISCARELLO RR COPPERMAN AB DEGENNARO NJ

Citation: Rr. Viscarello et al., IS THE RISK OF PERINATAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUSINCREASED BY THE INTRAPARTUM USE OF SPIRAL ELECTRODES OR FETAL SCALP PH SAMPLING, American journal of obstetrics and gynecology, 170(3), 1994, pp. 740-743